Logo for: PursueCare

Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans

[button title=”Back” link=”https://www.pursuecare.com/app-blog/” target=”” align=”” icon=”” icon_position=”” color=”#00a0d5″ font_color=”#ffffff” size=”very small” full_width=”” class=”” download=”” rel=”” onclick=””] Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans By Dr. Jessica Badichek, PharmD A recent study published in JAMA, the Journal of the American...

FDA supports development of over-the-counter naloxone

[button title=”Back” link=”https://www.pursuecare.com/app-blog/” target=”” align=”” icon=”” icon_position=”” color=”#00a0d5″ font_color=”#ffffff” size=”very small” full_width=”” class=”” download=”” rel=”” onclick=””] FDA supports development of over-the-counter naloxone By Dr. Jessica Badichek, PharmD A recent statement from FDA Commissioner Dr. Scott Gottlieb summarized the FDA’s new efforts in encouraging drug manufacturers...

Drug Overdoses linked to Synthetic Opioids

[button title=”Back” link=”https://www.pursuecare.com/app-blog/” target=”” align=”” icon=”” icon_position=”” color=”#00a0d5″ font_color=”#ffffff” size=”very small” full_width=”” class=”” download=”” rel=”” onclick=””] Drug Overdoses linked to Synthetic Opioids By Dr. Jessica Badichek, PharmD According to CDC analysis of the latest drug overdose death data, there were 63,632 drug overdose deaths in...

Addiction Treatment & Telemedicine: An Update

[button title=”Back” link=”https://www.pursuecare.com/app-blog/” target=”” align=”” icon=”” icon_position=”” color=”#00a0d5″ font_color=”#ffffff” size=”very small” full_width=”” class=”” download=”” rel=”” onclick=””] Addiction Treatment & Telemedicine: An Update By Dr. Jessica Badichek, PharmD The Centers for Medicare and Medicaid Services (CMS) recently published a report summarizing current evidence and practices in...
Woman sitting at laptop computer